Ketan R. Patel

Dr. Ketan R. Patel is an Indian entrepreneur, pharmacist, chairman & managing director of Troikaa Pharmaceuticals, a research-driven pharmaceutical company, with operations in over 80 countries.[1]

Dr. Ketan Patel
Dr. Ketan Rajnibhai Patel
Born
NationalityIndian
Alma materL. M. College of Pharmacy, Dharamsinh Desai University
Occupationpharmacist, businessman

Education and career

Dr. Patel is a Gold Medalist during his Bachelor of Pharmacy and Master of Pharmacy programs from L. M. College of Pharmacy, Ahmedabad. He has a Ph.D. in Pharmaceutical Technology from Dharamsinh Desai University, Gujarat.[2]

Dr. Patel instituted the “Rajnibhai.V. Patel Pharmlnnova Award” under the aegis of Department of Science and Technology (India).[3]

His journey of innovation can be found in a book titled, ‘THE INNOVATORS’, published by the Department of Science and Technology (India) Government of India.

Membership and boards

Dr. Patel is the Chairman of the Board of Governors at National Institute of Pharmaceutical Education & Research (NIPER),[4] Gandhinagar. He is also a member of Academic Council, National Forensic Sciences University, Ahmedabad (previously known as Gujarat Forensic Sciences University).[5]

He is the member of the Board of Governors at Gujarat Technological University, Ahmedabad.[6] He is a member of the Board of Directors, i-HUB,[7] one of the biggest startup institutes set up by the Government of Gujarat.

Inventions

Dr. Patel is the primary inventor & patent holder of a painless diclofenac injection[8][9] under the brand name – ‘DYNAPAR-AQ’ by Troikaa Pharmaceuticals Ltd. For this Government of India’s Department of Science & Industrial Research also conferred National Award in 2008.[10]

In 2008, he invented a quick penetrating solution of Diclofenac[11] for topical administration known as 'DYNAPAR QPS', for which he was conferred National Award in 2015 by Department of Science & Technology, Govt of India.[10]

Dr. Ketan Patel is the key innovator behind world's first Methylcobalamin Nasal Spray, commercialized as Naso B12, which corrects Vitamin B12 deficiency in the human body. Methylcobalamin Nasal Spray is also patented in European/Japanese markets.[12][13][14][15]

Other activities

Publications

References

  1. Talukdar, Tapash (8 September 2008). "The pain killer". The Economic Times.
  2. "L. M. College of Pharmacy". www.lmcp.ac.in.
  3. "PharmInnova Award". www.innovativethesisaward.org.
  4. "Board of Governers | About Us | National Institute of Pharmaceutical Education & Research". Niperahm.ac.in.
  5. "National Forensic Sciences University". www.nfsu.ac.in.
  6. "Gujarat Technological University". www.gtu.ac.in.
  7. "Board of Directors - i-Hub - A Government of Gujarat Initiative". ihubgujarat.in.
  8. Patel, Rajnibhai Ketan; Patel, Rajnibhai Milan (14 December 2006). "Injectable preparations of diclofenac and its pharmaceutically acceptable salts". {{cite journal}}: Cite journal requires |journal= (help)
  9. "Ketanbhai Rajnibhai Patel vs State Of Gujarat on 4 September, 2019". Indiankanoon.org.
  10. "Troikaa receives national award for commercialisation of indigenous technology". Pharmabiz.com.
  11. "A non-aqueous topical solution of diclofenac and process for preparing the same".
  12. "Eurasian Patent for Inventions". Eurasian Patent Organization.
  13. パテル, ケタン アール (13 January 2016). "Intranasal composition of vitamin B12". {{cite journal}}: Cite journal requires |journal= (help)
  14. Patel, Ketan R.; Patel, Milan R.; Shah, Prakashchandra J. (29 February 2016). "Nasal compositions of vitamin b12". {{cite journal}}: Cite journal requires |journal= (help)
  15. "Information about Granted Patents of Ukraine for Inventions". base.uipv.org.
  16. Patel, Ketan. "Ketan Patel".{{cite web}}: CS1 maint: url-status (link)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.